Anaplastic large cell lymphoma medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Anaplastic large cell lymphoma}} | {{Anaplastic large cell lymphoma}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{AS}} | ||
==Overview== | |||
==Medical Therapy== | ==Medical Therapy== | ||
===Chemotherapy=== | |||
* | |||
** | Anaplastic large cell lymphoma usually responds well to chemotherapy, so it often has a good prognosis. It is treated with the same combinations of chemotherapy drugs used to treat other aggressive lymphomas. | ||
* Drug Regimen:(CHOP)[[Cyclophosphamide]], {{and}} [[Doxorubicin]], {{and}} [[Vincristine]], {{and}} [[Prednisone]] | |||
===Radiation therapy=== | |||
* Radiation therapy is most often given after chemotherapy | |||
* External beam radiation therapy may be used | |||
:* When the lymphoma cells are only in one area of the lymph nodes (stage I primary systemic anaplastic large cell lymphoma) | |||
:* For localized skin lesions in primary cutaneous anaplastic large cell lymphoma | |||
* Overall better prognosis than other "Aggressive Lymphomas" | * Overall better prognosis than other "Aggressive Lymphomas" | ||
** ALK+ 5-year survival 70-80% | ** ALK+ 5-year survival 70-80% | ||
Revision as of 15:10, 6 October 2015
|
Anaplastic large cell lymphoma Microchapters |
|
Differentiating Anaplastic large cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Anaplastic large cell lymphoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Anaplastic large cell lymphoma medical therapy |
|
Directions to Hospitals Treating Anaplastic large cell lymphoma |
|
Risk calculators and risk factors for Anaplastic large cell lymphoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Medical Therapy
Chemotherapy
Anaplastic large cell lymphoma usually responds well to chemotherapy, so it often has a good prognosis. It is treated with the same combinations of chemotherapy drugs used to treat other aggressive lymphomas.
- Drug Regimen:(CHOP)Cyclophosphamide, AND Doxorubicin, AND Vincristine, AND Prednisone
Radiation therapy
- Radiation therapy is most often given after chemotherapy
- External beam radiation therapy may be used
- When the lymphoma cells are only in one area of the lymph nodes (stage I primary systemic anaplastic large cell lymphoma)
- For localized skin lesions in primary cutaneous anaplastic large cell lymphoma
- Overall better prognosis than other "Aggressive Lymphomas"
- ALK+ 5-year survival 70-80%
- ALK- 5-year survival 30-40%